Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|5|514-522

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.5, 2015-05, pp. : 514-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E98-E106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 663-666

John Wiley & Sons Inc

Access to resources Recommend Favorite

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 575-585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial

By  

Oncology, Vol. 89, Iss. 1, 2015-01 ,pp. : 23-30

Karger

Access to resources Recommend Favorite